Literature DB >> 8244578

Characterization of cell lines established from Merkel-cell ("small-cell") carcinoma of the skin.

J H Leonard1, J R Bell, J H Kearsley.   

Abstract

Six cell lines have been established from different biopsies of the rare small-cell skin cancer of neuro-endocrine origin known as Merkel-cell carcinoma (MCC). These were established from metastatic lesions and have now been in culture for periods varying from 1 to 3 years. All lines grow as suspension cultures and exhibit typical MCC cytological features of small round cells with little cytoplasm, round nuclei and tight junctions. There was variation in the number and size of nucleoli and dense-core granules. We present details of their immunohistochemistry and growth characteristics in culture. The latter were similar to small-cell lung-cancer (SCLC) lines and can be subdivided, by their appearance, into type I, type II and type III in the same way as SCLC lines. This classification may be of significance for the prognosis and management of MCC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244578     DOI: 10.1002/ijc.2910550519

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.

Authors:  Masahiro Shuda; Reety Arora; Hyun Jin Kwun; Huichen Feng; Ronit Sarid; María-Teresa Fernández-Figueras; Yanis Tolstov; Ole Gjoerup; Mahesh M Mansukhani; Steven H Swerdlow; Preet M Chaudhary; John M Kirkwood; Michael A Nalesnik; Jeffrey A Kant; Lawrence M Weiss; Patrick S Moore; Yuan Chang
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

2.  Epidermal tight junctions in health and disease.

Authors:  J M Brandner; M Zorn-Kruppa; T Yoshida; I Moll; L A Beck; A De Benedetto
Journal:  Tissue Barriers       Date:  2015-04-03

3.  Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.

Authors:  Kelly G Paulson; Andrew Tegeder; Christoph Willmes; Jayasri G Iyer; Olga K Afanasiev; David Schrama; Shinichi Koba; Renee Thibodeau; Kotaro Nagase; William T Simonson; Aaron Seo; David M Koelle; Margaret Madeleine; Shailender Bhatia; Hideki Nakajima; Shigetoshi Sano; James S Hardwick; Mary L Disis; Michele A Cleary; Jürgen C Becker; Paul Nghiem
Journal:  Cancer Immunol Res       Date:  2014-08-12       Impact factor: 11.151

4.  Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.

Authors:  Ioannis Gavvovidis; Matthias Leisegang; Gerald Willimsky; Natalie Miller; Paul Nghiem; Thomas Blankenstein
Journal:  Clin Cancer Res       Date:  2018-04-18       Impact factor: 12.531

Review 5.  Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management.

Authors: 
Journal:  J Clin Oncol       Date:  2009-07-13       Impact factor: 44.544

6.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus.

Authors:  Masahiro Shuda; Huichen Feng; Hyun Jin Kwun; Steven T Rosen; Ole Gjoerup; Patrick S Moore; Yuan Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

7.  Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression.

Authors:  Kishor Bhatia; James J Goedert; Rama Modali; Liliana Preiss; Leona W Ayers
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

8.  ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival.

Authors:  Jenni Jaatinen; Tuukka Veija; Marko Salmikangas; Tom Böhling; Harri Sihto; Virve Koljonen
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

9.  A practical update of surgical management of merkel cell carcinoma of the skin.

Authors:  Patricia Tai
Journal:  ISRN Surg       Date:  2013-01-30

10.  Atonal homolog 1 is a tumor suppressor gene.

Authors:  Wouter Bossuyt; Avedis Kazanjian; Natalie De Geest; Sofie Van Kelst; Gert De Hertogh; Karel Geboes; Greg P Boivin; Judith Luciani; Francois Fuks; Marinee Chuah; Thierry VandenDriessche; Peter Marynen; Jan Cools; Noah F Shroyer; Bassem A Hassan
Journal:  PLoS Biol       Date:  2009-02-24       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.